Lack of correlation between the effective dose of fentanyl sublingual spray for breakthrough cancer pain and the around-the-clock opioid dose.
CONCLUSIONS: These findings highlight the importance of titrating the dose of fentanyl sublingual spray to optimize dosing for individual patients.
PMID: 25162604 [PubMed - in process]
Source: Journal of Opioid Management - Category: Addiction Tags: J Opioid Manag Source Type: research
More News: Abstral | Addiction | Cancer | Cancer & Oncology | Chronic Pain | Fentanyl | Pain | Pain Management | Study